TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
Go back to TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus| (NASDAQ: TARS) | Delayed: 63.56 +0.40 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.16 | 52 Week High | $ | |||
| Open | $63.34 | 52 Week Low | $ | |||
| Day High | $64.21 | P/E | N/A | |||
| Day Low | $62.51 | EPS | $ | |||
| Volume | 788,704 | |||||

